大腸がん検診の世界市場規模、シェア、産業動向分析レポート：タイプ別、エンドユーザー別、地域別展望と予測、2023年～2030年

大腸がん検診市場規模は2030年までに222億米ドルに達し、予測期間中にCAGR 4.8%の市場成長率で上昇すると予測されています。

KBV Cardinalのマトリックスに示された分析によると、シーメンス・ヘルティニアスAGが市場の先駆者です。2021年4月、シーメンスはバリアンメディカルシステムズを買収し、シーメンス・ヘルスニイヤーズの競争力と独立性を強化しました。富士フイルムホールディングス株式会社、オリンパス株式会社、BioMerieux S.A.などの企業が市場における主要なイノベーターです。

COVID-19影響分析

COVID-19の影響により、パンデミックの間、市場の成長は鈍化しました。パンデミック時代の封鎖制限と大腸がん検診の中止がこれをもたらしました。人と人との接触を減らし、COVID-19に曝露した人々のために病院や医療資源を節約するため、大腸内視鏡によるスクリーニングは2020年に多くの国で完全に中止されました。パンデミック期間中、市場は売上高で見ると成長が鈍化しました。パンデミック期間中、政府プログラムによる検査対象者数が減少しました。

市場成長要因

大腸がんリスクの増大

世界の大腸がん罹患率の大幅な上昇は、市場拡大に好影響を与える重要な要因の1つです。罹患率は先進国で最も高く、中低所得国では不健康なライフスタイルの選択と人口の爆発的な高齢化のために上昇しています。また、米国がん協会によると、米国では2020年に直腸がんが43,340例、結腸がんが104,610例新たに確認されます。CRCの罹患率の上昇と同疾患の死亡率の上昇により、CRC検出の需要が高まっており、これが次年度以降の市場拡大の原動力となる可能性が高いです。

政府のがん検診政策

いくつかの国の政府は、世界規模で大腸がんの発生率を減らすためにスクリーニング政策を強化しています。数カ国の政府は、CRCの増加する負担を軽減するため、罹患リスクのある個人を対象とした定期的な検診プログラムなど、さまざまな取り組みを実施しています。2019年に国立医学図書館が発表した研究によると、韓国では国立がん検診プログラムが50歳以上のすべての成人にCRC検診を無料または低料金で提供しています。高齢者人口の増加や政府の取り組みにより、各種検査の利用が増加することが予想され、市場全体の拡大に弾みがつくと思われます。

市場抑制要因

大腸内視鏡検査の悪影響が検査導入の減少につながる可能性

高度で効率的なスクリーニング検査の必要性が高まっているにもかかわらず、スクリーニング検査機器の導入はその固有の制限によって妨げられる可能性があります。例えば、大腸内視鏡検査は最も陽性率が高く、精度の高い検査です。しかし、患者は出血や感染など、大腸内視鏡検査の過程でいくつかの副作用を経験する可能性があります。予測期間中、大腸がんスクリーニング技術に関連するこうした制限や好ましくない影響は、市場の拡大を抑制すると予想されます。

タイプ別展望

タイプ別では、便検査、大腸内視鏡検査、その他に区分されます。便ベースのセグメントは2022年の市場でかなりの収益シェアを占めています。便に基づく検査による大腸がんおよび前がん病変の診断は有望な結果を示しており、早期発見のための有用なツールとなっています。革新的な便ベースの検査は、便サンプルを分析して大腸がんに関連する特定のDNAマーカーを見つける。大腸がん検診のための政府プログラムの増加と便ベースの検査の効率性がこのセグメントの成長に寄与しています。

便ベースタイプの展望

便ベースのセグメントでは、市場はさらに便免疫化学検査（FIT）、便潜血検査（FOBT）、便DNA検査に分けられます。便免疫化学検査（FIT）セグメントは、2022年の市場で最大の収益シェアを示しました。FIT（便免疫化学検査）は、便中の血液を同定するために使用される非侵襲的診断手順です。FITは、便サンプル中の血液を検出することで、前がん病変や早期大腸がんを検出する診断ツールとして広く利用されています。FITの開発は、感度、特異度、患者への優しさを高めることに重点を置いています。

エンドユーザーの展望

エンドユーザーに基づき、市場は病院・診療所、臨床検査室、画像診断センター、その他に二分されます。2022年には、病院・診療所セグメントが最大収益シェアで市場を独占しました。このセグメントの成長は、大腸がんの有病率の上昇と、世界的に病院で実施されるスクリーニング検査の技術進歩に起因します。CRCスクリーニングの需要は、相当数の病院を含む要素により、病院や診療所で拡大しています。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、アジア太平洋地域が市場で大きな収益シェアを獲得しました。同地域市場の拡大は、アジア諸国におけるヘルスケア施設の市場開拓とアップグレード、同地域諸国におけるCRC罹患率の上昇、より良い治療結果に対する個人の意識の高まりが原動力となっています。また、同地域の主要国における大腸がんの罹患率の上昇や、大腸疾患が主要な死亡原因となっていることも、同地域の市場成長を促進すると予想されます。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第4章 競合分析- 世界

• KBV Cardinal Matrix
• 最近の業界全体の戦略的展開
  • パートナーシップ、コラボレーション、および契約
  • 製品の発売と製品の拡大
  • 買収と合併
  • 地理的拡大
• 主要成功戦略
  • 主な戦略
  • 主要な戦略的動き
• ポーターのファイブフォース分析

第5章 世界の結腸直腸がんスクリーニング市場：タイプ別

• 世界の大腸内視鏡検査市場：地域別
• 世界のスツールベース市場：地域別
• 世界の結腸直腸がんスクリーニング市場：スツールベースタイプ別
  • 世界の糞便免疫化学検査（FIT）市場：地域別
  • 世界の便潜血検査（FOBT）市場：地域別
  • 世界の便DNA検査市場：地域別
• 世界のその他の市場：地域別

第6章 世界の結腸直腸がんスクリーニング市場：エンドユーザー別

• 世界の病院およびクリニック市場：地域別
• 世界の臨床検査市場：地域別
• 世界の画像診断センター市場：地域別
• 世界のその他の市場：地域別

第7章 世界の結腸直腸がんスクリーニング市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

• Novigenix SA
• Eiken Chemical Co, Ltd.
• Clinical Genomics Pathology, Inc
• Exact Sciences Corporation
• Epigenomics AG
• BioMerieux SA
• Olympus Corporation
• Sysmex Corporation
• Siemens Healthineers AG（Siemens AG）
• Fujifilm Holdings Corporation

第9章 大腸がんスクリーニング市場での勝利は必須

LIST OF TABLES

• TABLE 1 Global Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 2 Global Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 3 Partnerships, Collaborations and Agreements- Colorectal Cancer Screening Market
• TABLE 4 Product Launches And Product Expansions- Colorectal Cancer Screening Market
• TABLE 5 Acquisition and Mergers- Colorectal Cancer Screening Market
• TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
• TABLE 7 Global Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 8 Global Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 9 Global Colonoscopy Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Colonoscopy Market by Region, 2023 - 2030, USD Million
• TABLE 11 Global Stool-based Market by Region, 2019 - 2022, USD Million
• TABLE 12 Global Stool-based Market by Region, 2023 - 2030, USD Million
• TABLE 13 Global Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 14 Global Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 15 Global Fecal Immunochemical Test (FIT) Market by Region, 2019 - 2022, USD Million
• TABLE 16 Global Fecal Immunochemical Test (FIT) Market by Region, 2023 - 2030, USD Million
• TABLE 17 Global Fecal Occult Blood Test (FOBT) Market by Region, 2019 - 2022, USD Million
• TABLE 18 Global Fecal Occult Blood Test (FOBT) Market by Region, 2023 - 2030, USD Million
• TABLE 19 Global Stool-DNA Test Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Stool-DNA Test Market by Region, 2023 - 2030, USD Million
• TABLE 21 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Others Market by Region, 2023 - 2030, USD Million
• TABLE 23 Global Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 24 Global Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 25 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
• TABLE 26 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
• TABLE 27 Global Clinical Laboratories Market by Region, 2019 - 2022, USD Million
• TABLE 28 Global Clinical Laboratories Market by Region, 2023 - 2030, USD Million
• TABLE 29 Global Diagnostic Imaging Centres Market by Region, 2019 - 2022, USD Million
• TABLE 30 Global Diagnostic Imaging Centres Market by Region, 2023 - 2030, USD Million
• TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
• TABLE 33 Global Colorectal Cancer Screening Market by Region, 2019 - 2022, USD Million
• TABLE 34 Global Colorectal Cancer Screening Market by Region, 2023 - 2030, USD Million
• TABLE 35 North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 36 North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 37 North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 38 North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 39 North America Colonoscopy Market by Country, 2019 - 2022, USD Million
• TABLE 40 North America Colonoscopy Market by Country, 2023 - 2030, USD Million
• TABLE 41 North America Stool-based Market by Country, 2019 - 2022, USD Million
• TABLE 42 North America Stool-based Market by Country, 2023 - 2030, USD Million
• TABLE 43 North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 44 North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 45 North America Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
• TABLE 46 North America Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
• TABLE 47 North America Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
• TABLE 48 North America Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
• TABLE 49 North America Stool-DNA Test Market by Country, 2019 - 2022, USD Million
• TABLE 50 North America Stool-DNA Test Market by Country, 2023 - 2030, USD Million
• TABLE 51 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 52 North America Others Market by Country, 2023 - 2030, USD Million
• TABLE 53 North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 54 North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 55 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
• TABLE 56 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
• TABLE 57 North America Clinical Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 58 North America Clinical Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 59 North America Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
• TABLE 60 North America Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
• TABLE 61 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 62 North America Others Market by Country, 2023 - 2030, USD Million
• TABLE 63 North America Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
• TABLE 64 North America Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
• TABLE 65 US Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 66 US Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 67 US Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 68 US Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 69 US Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 70 US Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 71 US Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 72 US Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 73 Canada Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 74 Canada Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 75 Canada Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 76 Canada Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 77 Canada Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 78 Canada Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 79 Canada Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 80 Canada Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 81 Mexico Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 82 Mexico Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 83 Mexico Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 84 Mexico Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 85 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 86 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 87 Mexico Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 88 Mexico Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 89 Rest of North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 90 Rest of North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 91 Rest of North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 92 Rest of North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 93 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 94 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 95 Rest of North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 96 Rest of North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 97 Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 98 Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 99 Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 100 Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 101 Europe Colonoscopy Market by Country, 2019 - 2022, USD Million
• TABLE 102 Europe Colonoscopy Market by Country, 2023 - 2030, USD Million
• TABLE 103 Europe Stool-based Market by Country, 2019 - 2022, USD Million
• TABLE 104 Europe Stool-based Market by Country, 2023 - 2030, USD Million
• TABLE 105 Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 106 Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 107 Europe Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
• TABLE 108 Europe Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
• TABLE 109 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
• TABLE 110 Europe Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
• TABLE 111 Europe Stool-DNA Test Market by Country, 2019 - 2022, USD Million
• TABLE 112 Europe Stool-DNA Test Market by Country, 2023 - 2030, USD Million
• TABLE 113 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 114 Europe Others Market by Country, 2023 - 2030, USD Million
• TABLE 115 Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 116 Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 117 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
• TABLE 118 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
• TABLE 119 Europe Clinical Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 120 Europe Clinical Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 121 Europe Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
• TABLE 122 Europe Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
• TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
• TABLE 125 Europe Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
• TABLE 126 Europe Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
• TABLE 127 Germany Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 128 Germany Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 129 Germany Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 130 Germany Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 131 Germany Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 132 Germany Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 133 Germany Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 134 Germany Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 135 UK Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 136 UK Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 137 UK Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 138 UK Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 139 UK Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 140 UK Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 141 UK Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 142 UK Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 143 France Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 144 France Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 145 France Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 146 France Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 147 France Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 148 France Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 149 France Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 150 France Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 151 Russia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 152 Russia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 153 Russia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 154 Russia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 155 Russia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 156 Russia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 157 Russia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 158 Russia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 159 Spain Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 160 Spain Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 161 Spain Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 162 Spain Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 163 Spain Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 164 Spain Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 165 Spain Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 166 Spain Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 167 Italy Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 168 Italy Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 169 Italy Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 170 Italy Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 171 Italy Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 172 Italy Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 173 Italy Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 174 Italy Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 175 Rest of Europe Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 176 Rest of Europe Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 177 Rest of Europe Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 178 Rest of Europe Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 179 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 180 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 181 Rest of Europe Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 182 Rest of Europe Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 183 Asia Pacific Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 184 Asia Pacific Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 185 Asia Pacific Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 186 Asia Pacific Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 187 Asia Pacific Colonoscopy Market by Country, 2019 - 2022, USD Million
• TABLE 188 Asia Pacific Colonoscopy Market by Country, 2023 - 2030, USD Million
• TABLE 189 Asia Pacific Stool-based Market by Country, 2019 - 2022, USD Million
• TABLE 190 Asia Pacific Stool-based Market by Country, 2023 - 2030, USD Million
• TABLE 191 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 192 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 193 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
• TABLE 194 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
• TABLE 195 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
• TABLE 196 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
• TABLE 197 Asia Pacific Stool-DNA Test Market by Country, 2019 - 2022, USD Million
• TABLE 198 Asia Pacific Stool-DNA Test Market by Country, 2023 - 2030, USD Million
• TABLE 199 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 200 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
• TABLE 201 Asia Pacific Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 202 Asia Pacific Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 203 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
• TABLE 204 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
• TABLE 205 Asia Pacific Clinical Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 206 Asia Pacific Clinical Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 207 Asia Pacific Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
• TABLE 208 Asia Pacific Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
• TABLE 209 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 210 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
• TABLE 211 Asia Pacific Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
• TABLE 212 Asia Pacific Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
• TABLE 213 China Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 214 China Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 215 China Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 216 China Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 217 China Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 218 China Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 219 China Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 220 China Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 221 Japan Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 222 Japan Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 223 Japan Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 224 Japan Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 225 Japan Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 226 Japan Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 227 Japan Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 228 Japan Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 229 India Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 230 India Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 231 India Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 232 India Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 233 India Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 234 India Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 235 India Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 236 India Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 237 South Korea Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 238 South Korea Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 239 South Korea Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 240 South Korea Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 241 South Korea Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 242 South Korea Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 243 South Korea Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 244 South Korea Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 245 Singapore Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 246 Singapore Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 247 Singapore Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 248 Singapore Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 249 Singapore Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 250 Singapore Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 251 Singapore Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 252 Singapore Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 253 Malaysia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 254 Malaysia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 255 Malaysia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 256 Malaysia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 257 Malaysia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 258 Malaysia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 259 Malaysia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 260 Malaysia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
• TABLE 261 Rest of Asia Pacific Colorectal Cancer Screening Market, 2019 - 2022, USD Million
• TABLE 262 Rest of Asia Pacific Colorectal Cancer Screening Market, 2023 - 2030, USD Million
• TABLE 263 Rest of Asia Pacific Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
• TABLE 264 Rest of Asia Pacific Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
• TABLE 265 Rest of Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
• TABLE 266 Rest of Asia Pacific Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
• TABLE 267 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
• TABLE 268 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million

The Global Colorectal Cancer Screening Market size is expected to reach $22.2 billion by 2030, rising at a market growth of 4.8% CAGR during the forecast period.

In United States, approximately nine out of ten people with colorectal cancer who are diagnosed early and treated appropriately are still alive five years later. Hence, the North America region would capture approximately 2/5th of the market by 2030. Due to several factors, including an aging population, an increase in cancer cases, high healthcare spending, and a modern healthcare infrastructure. The market is also expanding due to rising government initiatives to create awareness of the disease and the accessibility of screening tests like FIT and FOBT.

The major strategies followed by the market participants are Acquisitions as the key developmental strategy in order to keep pace with the changing demands of end users. For instance, In April, 2022, BioMerieux S.A. acquired Specific Diagnostics to enhances bioMerieux's capability to deliver instant AST results by adding specific Diagnostics' SPECIFIC REVEAL Rapid AST offerings to its portfolio. In December, 2022, Olympus Corporation took over Odin Vision to reinforce Olympus' strategy for delivering digital patient care.

Based on the Analysis presented in the KBV Cardinal matrix; Siemens Healthineers AG is the forerunner in the Market. April, 2021, Siemens took over Varian Medical Systems to strengthen the competitiveness & independence of Siemens Healthineers. Companies such as Fujifilm Holdings Corporation, Olympus Corporation, BioMerieux S.A. are some of the key innovators in the Market.

COVID-19 Impact Analysis

The COVID-19 effect caused the market growth to slow down during the pandemic. Pandemic-era lockdown limitations and a suspension of colorectal cancer screening brought this on. To decrease person-to-person contact and conserve hospital and medical resources for those exposed to COVID-19, screening through colonoscopies was completely discontinued in many countries in 2020. The market slowed in growth during the pandemic period when measured by revenue. During the pandemic, there was a decrease in the number of people being examined through government programs.

Market Growth Factors

Growing Risk of Colorectal Cancer

The substantial rise in global colorectal cancer incidence is one of the key factors that favorably influence the market's expansion. The incidence is highest in developed nations, rising in middle- and low-income nations because of unhealthy lifestyle choices and an aging population explosion. Additionally, according to the American Cancer Society, 43,340 new instances of rectal cancer and 104,610 new cases of colon cancer were identified in the United States in 2020, respectively. The demand for CRC detection has increased due to the rising incidence of CRC and the disease's rising death rate, which will likely drive the expansion of the market in the following years.

Government Cancer Screening Policies

Governments in several nations have strengthened screening policies to reduce the incidence of colorectal cancer on a global scale. Governments in several nations have implemented various initiatives, such as regular screening programs for individuals at risk of contracting the disease, to reduce the growing burden of CRC. In Korea, the National Cancer Screening Program offers CRC screening to all adults over 50 at no or at a low cost, according to a study released by the National Library of Medicine in 2019. The usage of various tests is anticipated to increase due to the growing elderly population and government initiatives, which will fuel market expansion overall.

Market Restraining Factors

Negative Effects of Colonoscopies May Lead to Decreased Adoption of Testing

Despite the critical and growing need for advanced and efficient screening procedures, adopting screening devices may be hampered by their inherent limitations. A colonoscopy, for instance, has the highest incidence of positive results and is a highly accurate test. However, the patient may experience several negative side effects from the colonoscopy process, including bleeding and infection. During the forecast period, these restrictions and unfavorable effects related to colorectal cancer screening techniques are anticipated to restrain market expansion.

Type Outlook

By type, the market is segmented into stool-based, colonoscopy, and others. The stool-based segment covered a considerable revenue share in the market in 2022. The diagnosis of colorectal cancer and precancerous lesions using stool-based tests has shown encouraging results, making it a useful tool for early detection. The revolutionary stool-based tests analyze stool samples to find specific DNA markers related to colorectal cancer. Increased government programs for colorectal cancer screening and the efficiency of stool-based tests have contributed to the segment's growth.

Stool-based type Outlook

Under the stool-based segment, the market is further divided into fecal immunochemical test (FIT), fecal occult blood test (FOBT), and stool-DNA test. The fecal immunochemical test (FIT) segment witnessed the largest revenue share in the market in 2022. The FIT, or fecal immunochemical test, is a non-invasive diagnostic procedure used to identify blood in stool. FITs are extensively utilized diagnostic tools for detecting precancerous lesions or early-stage colorectal cancer by detecting blood in stool samples. The development of FITs has focused on enhancing their sensitivity, specificity, and patient friendliness.

End-user Outlook

Based on end-user, the market is bifurcated into hospital & clinics, clinical laboratories, diagnostic imaging centers, and others. In 2022, the hospitals and clinics segment dominated the market with maximum revenue share. The growth of the segment is attributable to the rise in the prevalence of colorectal cancer and technological advancements in screening tests conducted in hospitals globally. The demand for CRC screening is expanding in hospitals and clinics due to elements including a sizable number of hospitals.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a significant revenue share in the market. The expansion of the regional market is driven by the development and upgrading of healthcare facilities in Asian nations, rising CRC incidence in the region's nations, and rising individual consciousness of better treatment outcomes. It is expected that the rising incidence of colorectal cancer in the region's key countries and the status of colorectal diseases as the primary cause of mortality will also drive market growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG)

Strategies deployed in Colorectal Cancer Screening Market

Jul-2023: BioMerieux S.A. signed a partnership with Oxford Nanopore, a medical technology company, to provide nanopore sequencing solutions within the infectious disease diagnostics market. The partnership provides BioMerieux with opportunities for exploring new technologies for improved patient care.

Dec-2022: Olympus Corporation took over Odin Vision, an endoscopy solutions provider. The acquisition reinforces Olympus' strategy for delivering digital patient care.

Apr-2022: BioMerieux S.A. acquired Specific Diagnostics, an antimicrobial susceptibility test (AST) specialist. The acquisition enhances bioMerieux's capability to deliver instant AST results by adding specific Diagnostics' SPECIFIC REVEAL Rapid AST offerings to its portfolio.

May-2021: Fujifilm Holdings Corporation signed a partnership with Helio Health, an AI-powered healthcare solutions provider, to develop solutions for early detection of liver cancer. The partnership would provide clinicians around the world with market-leading diagnostic and surveillance technologies.

Apr-2021: Siemens took over Varian Medical Systems, a U.S. company active in the region of cancer research & therapy. This acquisition would allow Siemens to strengthen the competitiveness & independence of Siemens Healthineers. The acquisition further focused on creating a world-leading company in cancer therapy.

Jan-2021: Fujifilm Holdings Corporation expanded its geographical footprint by opening a new centre named "NURA" in Bangalore, India. The centre would serve as a medical screening service business for the company.

Scope of the Study

Market Segments covered in the Report:

By Type

• Colonoscopy
• Stool-based
  • Fecal Immunochemical Test (FIT)
  • Fecal Occult Blood Test (FOBT)
  • Stool-DNA Test
• Others

By End-user

• Hospitals & Clinics
• Clinical Laboratories
• Diagnostic Imaging Centres
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Novigenix SA
• Eiken Chemical Co., Ltd.
• Clinical Genomics Pathology, Inc.
• Exact Sciences Corporation
• Epigenomics AG
• BioMerieux S.A.
• Olympus Corporation
• Sysmex Corporation
• Fujifilm Holdings Corporation
• Siemens Healthineers AG (Siemens AG)

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Colorectal Cancer Screening Market, by Type
  • 1.4.2 Global Colorectal Cancer Screening Market, by End-user
  • 1.4.3 Global Colorectal Cancer Screening Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
  • 4.2.4 Geographical Expansions
• 4.3 Top Winning Strategies
  • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul - 2022, Dec) Leading Players
• 4.4 Porter's Five Forces Analysis

Chapter 5. Global Colorectal Cancer Screening Market by Type

• 5.1 Global Colonoscopy Market by Region
• 5.2 Global Stool-based Market by Region
• 5.3 Global Colorectal Cancer Screening Market by Stool-based Type
  • 5.3.1 Global Fecal Immunochemical Test (FIT) Market by Region
  • 5.3.2 Global Fecal Occult Blood Test (FOBT) Market by Region
  • 5.3.3 Global Stool-DNA Test Market by Region
• 5.4 Global Others Market by Region

Chapter 6. Global Colorectal Cancer Screening Market by End-user

• 6.1 Global Hospitals & Clinics Market by Region
• 6.2 Global Clinical Laboratories Market by Region
• 6.3 Global Diagnostic Imaging Centres Market by Region
• 6.4 Global Others Market by Region

Chapter 7. Global Colorectal Cancer Screening Market by Region

• 7.1 North America Colorectal Cancer Screening Market
  • 7.1.1 North America Colorectal Cancer Screening Market by Type
    • 7.1.1.1 North America Colonoscopy Market by Country
    • 7.1.1.2 North America Stool-based Market by Country
    • 7.1.1.3 North America Colorectal Cancer Screening Market by Stool-based Type
      • 7.1.1.3.1 North America Fecal Immunochemical Test (FIT) Market by Country
      • 7.1.1.3.2 North America Fecal Occult Blood Test (FOBT) Market by Country
      • 7.1.1.3.3 North America Stool-DNA Test Market by Country
    • 7.1.1.4 North America Others Market by Country
  • 7.1.2 North America Colorectal Cancer Screening Market by End-user
    • 7.1.2.1 North America Hospitals & Clinics Market by Country
    • 7.1.2.2 North America Clinical Laboratories Market by Country
    • 7.1.2.3 North America Diagnostic Imaging Centres Market by Country
    • 7.1.2.4 North America Others Market by Country
  • 7.1.3 North America Colorectal Cancer Screening Market by Country
    • 7.1.3.1 US Colorectal Cancer Screening Market
      • 7.1.3.1.1 US Colorectal Cancer Screening Market by Type
      • 7.1.3.1.2 US Colorectal Cancer Screening Market by End-user
    • 7.1.3.2 Canada Colorectal Cancer Screening Market
      • 7.1.3.2.1 Canada Colorectal Cancer Screening Market by Type
      • 7.1.3.2.2 Canada Colorectal Cancer Screening Market by End-user
    • 7.1.3.3 Mexico Colorectal Cancer Screening Market
      • 7.1.3.3.1 Mexico Colorectal Cancer Screening Market by Type
      • 7.1.3.3.2 Mexico Colorectal Cancer Screening Market by End-user
    • 7.1.3.4 Rest of North America Colorectal Cancer Screening Market
      • 7.1.3.4.1 Rest of North America Colorectal Cancer Screening Market by Type
      • 7.1.3.4.2 Rest of North America Colorectal Cancer Screening Market by End-user
• 7.2 Europe Colorectal Cancer Screening Market
  • 7.2.1 Europe Colorectal Cancer Screening Market by Type
    • 7.2.1.1 Europe Colonoscopy Market by Country
    • 7.2.1.2 Europe Stool-based Market by Country
    • 7.2.1.3 Europe Colorectal Cancer Screening Market by Stool-based Type
      • 7.2.1.3.1 Europe Fecal Immunochemical Test (FIT) Market by Country
      • 7.2.1.3.2 Europe Fecal Occult Blood Test (FOBT) Market by Country
      • 7.2.1.3.3 Europe Stool-DNA Test Market by Country
    • 7.2.1.4 Europe Others Market by Country
  • 7.2.2 Europe Colorectal Cancer Screening Market by End-user
    • 7.2.2.1 Europe Hospitals & Clinics Market by Country
    • 7.2.2.2 Europe Clinical Laboratories Market by Country
    • 7.2.2.3 Europe Diagnostic Imaging Centres Market by Country
    • 7.2.2.4 Europe Others Market by Country
  • 7.2.3 Europe Colorectal Cancer Screening Market by Country
    • 7.2.3.1 Germany Colorectal Cancer Screening Market
      • 7.2.3.1.1 Germany Colorectal Cancer Screening Market by Type
      • 7.2.3.1.2 Germany Colorectal Cancer Screening Market by End-user
    • 7.2.3.2 UK Colorectal Cancer Screening Market
      • 7.2.3.2.1 UK Colorectal Cancer Screening Market by Type
      • 7.2.3.2.2 UK Colorectal Cancer Screening Market by End-user
    • 7.2.3.3 France Colorectal Cancer Screening Market
      • 7.2.3.3.1 France Colorectal Cancer Screening Market by Type
      • 7.2.3.3.2 France Colorectal Cancer Screening Market by End-user
    • 7.2.3.4 Russia Colorectal Cancer Screening Market
      • 7.2.3.4.1 Russia Colorectal Cancer Screening Market by Type
      • 7.2.3.4.2 Russia Colorectal Cancer Screening Market by End-user
    • 7.2.3.5 Spain Colorectal Cancer Screening Market
      • 7.2.3.5.1 Spain Colorectal Cancer Screening Market by Type
      • 7.2.3.5.2 Spain Colorectal Cancer Screening Market by End-user
    • 7.2.3.6 Italy Colorectal Cancer Screening Market
      • 7.2.3.6.1 Italy Colorectal Cancer Screening Market by Type
      • 7.2.3.6.2 Italy Colorectal Cancer Screening Market by End-user
    • 7.2.3.7 Rest of Europe Colorectal Cancer Screening Market
      • 7.2.3.7.1 Rest of Europe Colorectal Cancer Screening Market by Type
      • 7.2.3.7.2 Rest of Europe Colorectal Cancer Screening Market by End-user
• 7.3 Asia Pacific Colorectal Cancer Screening Market
  • 7.3.1 Asia Pacific Colorectal Cancer Screening Market by Type
    • 7.3.1.1 Asia Pacific Colonoscopy Market by Country
    • 7.3.1.2 Asia Pacific Stool-based Market by Country
    • 7.3.1.3 Asia Pacific Colorectal Cancer Screening Market by Stool-based Type
      • 7.3.1.3.1 Asia Pacific Fecal Immunochemical Test (FIT) Market by Country
      • 7.3.1.3.2 Asia Pacific Fecal Occult Blood Test (FOBT) Market by Country
      • 7.3.1.3.3 Asia Pacific Stool-DNA Test Market by Country
    • 7.3.1.4 Asia Pacific Others Market by Country
  • 7.3.2 Asia Pacific Colorectal Cancer Screening Market by End-user
    • 7.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
    • 7.3.2.2 Asia Pacific Clinical Laboratories Market by Country
    • 7.3.2.3 Asia Pacific Diagnostic Imaging Centres Market by Country
    • 7.3.2.4 Asia Pacific Others Market by Country
  • 7.3.3 Asia Pacific Colorectal Cancer Screening Market by Country
    • 7.3.3.1 China Colorectal Cancer Screening Market
      • 7.3.3.1.1 China Colorectal Cancer Screening Market by Type
      • 7.3.3.1.2 China Colorectal Cancer Screening Market by End-user
    • 7.3.3.2 Japan Colorectal Cancer Screening Market
      • 7.3.3.2.1 Japan Colorectal Cancer Screening Market by Type
      • 7.3.3.2.2 Japan Colorectal Cancer Screening Market by End-user
    • 7.3.3.3 India Colorectal Cancer Screening Market
      • 7.3.3.3.1 India Colorectal Cancer Screening Market by Type
      • 7.3.3.3.2 India Colorectal Cancer Screening Market by End-user
    • 7.3.3.4 South Korea Colorectal Cancer Screening Market
      • 7.3.3.4.1 South Korea Colorectal Cancer Screening Market by Type
      • 7.3.3.4.2 South Korea Colorectal Cancer Screening Market by End-user
    • 7.3.3.5 Singapore Colorectal Cancer Screening Market
      • 7.3.3.5.1 Singapore Colorectal Cancer Screening Market by Type
      • 7.3.3.5.2 Singapore Colorectal Cancer Screening Market by End-user
    • 7.3.3.6 Malaysia Colorectal Cancer Screening Market
      • 7.3.3.6.1 Malaysia Colorectal Cancer Screening Market by Type
      • 7.3.3.6.2 Malaysia Colorectal Cancer Screening Market by End-user
    • 7.3.3.7 Rest of Asia Pacific Colorectal Cancer Screening Market
      • 7.3.3.7.1 Rest of Asia Pacific Colorectal Cancer Screening Market by Type
      • 7.3.3.7.2 Rest of Asia Pacific Colorectal Cancer Screening Market by End-user
• 7.4 LAMEA Colorectal Cancer Screening Market
  • 7.4.1 LAMEA Colorectal Cancer Screening Market by Type
    • 7.4.1.1 LAMEA Colonoscopy Market by Country
    • 7.4.1.2 LAMEA Stool-based Market by Country
    • 7.4.1.3 LAMEA Colorectal Cancer Screening Market by Stool-based Type
      • 7.4.1.3.1 LAMEA Fecal Immunochemical Test (FIT) Market by Country
      • 7.4.1.3.2 LAMEA Fecal Occult Blood Test (FOBT) Market by Country
      • 7.4.1.3.3 LAMEA Stool-DNA Test Market by Country
    • 7.4.1.4 LAMEA Others Market by Country
  • 7.4.2 LAMEA Colorectal Cancer Screening Market by End-user
    • 7.4.2.1 LAMEA Hospitals & Clinics Market by Country
    • 7.4.2.2 LAMEA Clinical Laboratories Market by Country
    • 7.4.2.3 LAMEA Diagnostic Imaging Centres Market by Country
    • 7.4.2.4 LAMEA Others Market by Country
  • 7.4.3 LAMEA Colorectal Cancer Screening Market by Country
    • 7.4.3.1 Brazil Colorectal Cancer Screening Market
      • 7.4.3.1.1 Brazil Colorectal Cancer Screening Market by Type
      • 7.4.3.1.2 Brazil Colorectal Cancer Screening Market by End-user
    • 7.4.3.2 Argentina Colorectal Cancer Screening Market
      • 7.4.3.2.1 Argentina Colorectal Cancer Screening Market by Type
      • 7.4.3.2.2 Argentina Colorectal Cancer Screening Market by End-user
    • 7.4.3.3 UAE Colorectal Cancer Screening Market
      • 7.4.3.3.1 UAE Colorectal Cancer Screening Market by Type
      • 7.4.3.3.2 UAE Colorectal Cancer Screening Market by End-user
    • 7.4.3.4 Saudi Arabia Colorectal Cancer Screening Market
      • 7.4.3.4.1 Saudi Arabia Colorectal Cancer Screening Market by Type
      • 7.4.3.4.2 Saudi Arabia Colorectal Cancer Screening Market by End-user
    • 7.4.3.5 South Africa Colorectal Cancer Screening Market
      • 7.4.3.5.1 South Africa Colorectal Cancer Screening Market by Type
      • 7.4.3.5.2 South Africa Colorectal Cancer Screening Market by End-user
    • 7.4.3.6 Nigeria Colorectal Cancer Screening Market
      • 7.4.3.6.1 Nigeria Colorectal Cancer Screening Market by Type
      • 7.4.3.6.2 Nigeria Colorectal Cancer Screening Market by End-user
    • 7.4.3.7 Rest of LAMEA Colorectal Cancer Screening Market
      • 7.4.3.7.1 Rest of LAMEA Colorectal Cancer Screening Market by Type
      • 7.4.3.7.2 Rest of LAMEA Colorectal Cancer Screening Market by End-user

Chapter 8. Company Profiles

• 8.1 Novigenix SA
  • 8.1.1 Company Overview
  • 8.1.2 SWOT Analysis
• 8.2 Eiken Chemical Co., Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Research & Development Expenses
• 8.3 Clinical Genomics Pathology, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Recent strategies and developments:
    • 8.3.2.1 Partnerships, Collaborations, and Agreements:
  • 8.3.3 SWOT Analysis
• 8.4 Exact Sciences Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Regional Analysis
  • 8.4.4 Research & Development Expenses
  • 8.4.5 Recent strategies and developments:
    • 8.4.5.1 Acquisition and Mergers:
  • 8.4.6 SWOT Analysis
• 8.5 Epigenomics AG
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Regional Analysis
  • 8.5.4 Research & Development Expenses
  • 8.5.5 SWOT Analysis
• 8.6 BioMerieux S.A.
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Segmental and Regional Analysis
  • 8.6.4 Research & Development Expenses
  • 8.6.5 Recent strategies and developments:
    • 8.6.5.1 Partnerships, Collaborations, and Agreements:
    • 8.6.5.2 Acquisition and Mergers:
  • 8.6.6 SWOT Analysis
• 8.7 Olympus Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental and Regional Analysis
  • 8.7.4 Research & Development Expenses
  • 8.7.5 Recent strategies and developments:
    • 8.7.5.1 Partnerships, Collaborations, and Agreements:
    • 8.7.5.2 Product Launches and Product Expansions:
    • 8.7.5.3 Acquisition and Mergers:
  • 8.7.6 SWOT Analysis
• 8.8 Sysmex Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Financial Analysis
  • 8.8.3 Regional Analysis
  • 8.8.4 Research & Development Expense
  • 8.8.5 SWOT Analysis
• 8.9 Siemens Healthineers AG (Siemens AG)
  • 8.9.1 Company Overview
  • 8.9.2 Financial Analysis
  • 8.9.3 Segmental and Regional Analysis
  • 8.9.4 Research & Development Expense
    • 8.9.4.1 Acquisition and Mergers:
  • 8.9.5 SWOT Analysis
• 8.10. Fujifilm Holdings Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 Segmental and Regional Analysis
  • 8.10.4 Research & Development Expenses
  • 8.10.5 Recent strategies and developments:
    • 8.10.5.1 Partnerships, Collaborations, and Agreements:
    • 8.10.5.2 Product Launches and Product Expansions:
    • 8.10.5.3 Geographical Expansions:
  • 8.10.6 SWOT Analysis

Chapter 9. Winning Imperative for Colorectal Cancer Screening Market